Mild systemic inflammation enhances response to OnabotulinumtoxinA in chronic migraineurs

Abstract The anti-inflammatory effect of OnabotulinumtoxinA (OnabotA) has been a matter of discussion for many years. In chronic migraine, however, increased pro-inflammatory state is associated with good response to OnabotA. We aimed to investigate whether a mild systemic inflammatory state elicite...

Full description

Bibliographic Details
Main Authors: Yago Leira, Clara Domínguez, Pablo Ameijeira, Esteban López-Arias, Paulo Ávila-Gómez, María Pérez-Mato, Tomás Sobrino, Francisco Campos, Juan Blanco, Rogelio Leira
Format: Article
Language:English
Published: Nature Publishing Group 2021-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-020-80283-4